2nd Quarter - Report
FEROX STRATEGIES for VIATRIS INC
Firm
Client
Income
$70,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| DEBRA DIXON | — |
| MICHAEL TAGGART | — |
| MARK WILLIAMS | — |
Foreign Relations FOR
Issues related to PEPFAR.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| MICHAEL TAGGART | — |
| MARK WILLIAMS | — |
Trade (domestic/foreign) TRD
ITrade issues related to generic medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.